Vistagen Therapeutics, Inc. (VTGN)
0.5299
-0.01
(-1.47%)
USD |
NASDAQ |
Jun 10, 16:00
0.5299
0.00 (0.00%)
After-Hours: 17:05
Vistagen Therapeutics Profit Margin (Quarterly) : -6.24K% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | -6.24K% |
| September 30, 2025 | -7.53K% |
| June 30, 2025 | -6.19K% |
| December 31, 2024 | -6.02K% |
| September 30, 2024 | -7.08K% |
| June 30, 2024 | -12.78K% |
| March 31, 2024 | -4.83K% |
| December 31, 2023 | -1.54K% |
| September 30, 2023 | -2.37K% |
| June 30, 2023 | -3.89K% |
| March 31, 2023 | -6.96K% |
| December 31, 2022 | -5.43K% |
| September 30, 2022 | |
| June 30, 2022 | -6.38K% |
| March 31, 2022 | -42.79K% |
| December 31, 2021 | -2.94K% |
| September 30, 2021 | -3.57K% |
| June 30, 2021 | -2.19K% |
| March 31, 2021 | -1.41K% |
| December 31, 2020 | -1.69K% |
| September 30, 2020 | -987.4% |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 |
| Date | Value |
|---|---|
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | -211.1% |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.36% |
| Alnylam Pharmaceuticals, Inc. | 17.65% |
| Savara, Inc. | -- |
| Vericel Corp. | -9.21% |
| Biogen, Inc. | 13.29% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -96.95% |
| Return on Assets | -82.37% |
| Return on Invested Capital | -94.46% |
| Gross Profit Margin (Quarterly) | 37.62% |
| Operating Margin (Quarterly) | -6.45K% |
| Return on Net Operating Assets | -3.89K% |